Reporting for CBS News’ Money Watch column, Arthur Allen of KFF Health News featured NCPA CEO Douglas Hoey in its recent report on broken promises as PBMs deduct “performance fees” from checks owed to pharmacies for the drugs they buy wholesale and dispense to patients. That's part of what Allen calls the “double whammy” of the DIR hangover in January, when PBMs are set to pay pharmacies less for the drugs while also dissing them on Q4 clawbacks from 2023.
On Tuesday, NCPA CEO Douglas Hoey joined a panel discussion entitled, “Perspectives on Advancing Pharmacy Practice" at NCPDP’s 2023 Virtual Educational Summit and shared NCPA’s top advocacy initiatives and points of strategic alignment with other association executives. Hoey was joined by APhA CEO Michael Hogue, ASHP COO and SVP Kasey Thompson, and NCPDP SVP Stephen Mullenix, and the discussion covered PBM reform, banning spread pricing in Medicaid managed care, and Medicare Part D reform.
Reporting for CBS News’ Money Watch column, Arthur Allen of KFF Health News featured NCPA CEO Douglas Hoey in its report on broken promises as PBMs deduct “performance fees” from checks owed to pharmacies for the drugs they buy wholesale and dispense to patients. That's part of what Allen calls the “double whammy” of the DIR hangover in January, when PBMs are set to pay pharmacies less for the drugs while also dissing them on Q4 clawbacks from 2023.
Dear Colleague, There's a time for planning and there's a time for doing and one of the great things about NCPA's annual Steering Committee Forum is that it's a time for both.